Selling Your Imaging Center: What Buyers Actually Pay

Roughly $12,000,000. About $9,400,000. Same imaging group, same LOI — the first number is what a private-equity-backed buyer offered to get in the door, the second is what they actually closed at after due diligence.

That gap was not lost in negotiation. It was set in diligence — and that reset is not a glitch in the process. It is the process.

Key Takeaway: Private-equity-backed platforms (and public strategics) are consolidating imaging and radiology, and the deal pattern is consistent: a friendly Letter of Intent (LOI) at a headline multiple wins your exclusivity, then due diligence uses your own add-backs and revenue-durability gaps to reset the price before close. Buyers do not pay on the EBITDA your P&L shows — they pay on Adjusted EBITDA that survives a Quality of Earnings (QofE) review, valued through the Two Business Unit Framework that separates high-reimbursement PET Tracer income from durable Radiology income because the two do not earn the same multiple. And the multiple is the easy part: rollover equity, earnouts, and escrows decide what you actually pocket. Before any of that, answer the one question that sets your price — are you selling a fixer-upper or a walk-in-ready center? You can get a defensible estimate of your Adjusted EBITDA now, or learn it in the data room. A Strategic Radiology Review gets you the first.

What Buyers Actually Pay On: SDE vs EBITDA vs Adjusted EBITDA

Three different earnings numbers get used in imaging-center deals, and which one applies to you depends almost entirely on your size. Confusing them is the single most common reason owners walk in with the wrong expectation.

Here is the trap. SDE adds your salary back because a small-practice buyer steps into your seat — so SDE multiples are correspondingly lower, generally in the 1.5x–3x range. Adjusted EBITDA subtracts a market-rate manager because a platform buyer hires one. An owner who hears "platforms trade at 6x" and applies it to an SDE number is double-counting their own paycheck — and inflating the expectation by a full salary.

Realistic SE Florida imaging EBITDA multiples in 2026, consistent with the buyer-side bands in our companion piece on acquiring a second imaging center:

Two things sit behind that table. The bottom of the range — 2.5x — is distressed territory; a clean, stable single center rarely clears below about 3.5x, so do not let an LOI anchor you there. And the top is uncapped: a genuine multi-center, AI-equipped, commercial-payer-heavy platform can reach well into double-digit multiples, which is the entire economic engine of the roll-up. The multiple is always a band, not a number — and the LOI almost always quotes the top of the band. Where you actually land is decided in diligence, which is where the playbook begins.

The PE Playbook: The Friendly LOI, Then the Reset

If a banker has called, or a competitor has hinted, or a consolidator has started buying centers near you, it is not a coincidence — imaging is a targeted roll-up category, and you are being approached on purpose. Fragmented ownership, real estate, recurring demand, and a clear path to multiple-arbitrage when small centers get bundled into a platform that trades higher. That is the setup, and it is a legitimate strategy. The risk is not that buyers are villains. The risk is information asymmetry — they run this play constantly, and you run it once.

Here is the sequence almost every owner experiences:

1. The friendly LOI. A buyer offers a headline number at an attractive multiple. It is non-binding by design. Its job is less to set the final price than to win your exclusivity and frame the deal.
2. The no-shop. You sign, agreeing not to talk to other buyers, typically for 60–90 days (PE buyers often push toward 120). The moment you do, your leverage transfers to the buyer. There is no longer a competing bid in the room.
3. Diligence. The Quality of Earnings team arrives and tests every add-back and revenue assumption — almost always the same items a sell-side QofE would have flagged in advance.
4. The reset. Weeks in, with advisory fees paid and the number already spent in your head, a revised price appears. Often it is lower. You are committed and short on alternatives. Many owners accept it.

This is not fraud-hunting. The price reset is built from your own EBITDA bridge — the "one-time" legal expense that has recurred four years running, the family member on payroll a buyer would have to replace, the deferred equipment maintenance, the referral concentration. The general-business version of this — a $5.2M LOI that fell to $1.8M in diligence — is laid out in Fixer Upper or Walk-In Ready; that is the same mechanic in a more extreme form. The defense is not better negotiating. It is removing the ammunition before the no-shop is ever signed.

The Number Behind the Number: Deal Terms That Decide What You Pocket

Owners fixate on the multiple. Experienced buyers know the multiple is the easiest thing to concede, because the structure is where the real economics live. A "6x" deal where most of the value is contingent or illiquid is not 6x of anything you can spend on day one.

The most misread term is rollover equity. Done well, it is a genuine "second bite of the apple" — the rolled stake can be worth more than the cash at close when the platform sells again in 3–7 years. Done badly, it is a minority position you cannot sell until the sponsor exits, often struck at the leveraged platform level and junior to the sponsor's preferred return. Rollover is not lost money — it is contingent, illiquid money. The point is simply to separate it from cash. A 6x headline with heavy rollover and a meaningful earnout can leave the cash you can actually spend on day one equal to roughly 3x EBITDA, with the rest riding on the platform's future. Know that split before you celebrate the multiple.

Are You Selling a Fixer-Upper or a Walk-In-Ready Center?

This is the one question that sets your price, and you can answer it honestly long before a buyer does it for you. A fixer-upper business gets a fixer-upper price — every time. The only question is whether the buyer's inspection report tells you that, or you tell yourself first.

A walk-in-ready imaging center has: clean, reconciled books; a diversified referral base; a balanced payer mix; modern equipment with no imminent capex cliff; positive equity; improving trends across the last 3–4 quarters; and a PET-vs-radiology split that is legible rather than buried. A buyer pays a full multiple for it because there is little to discount.

A fixer-upper has the opposite: concentrated referrers, an LOP-heavy book with a deteriorating yield curve, deferred maintenance, owner-dependent operations, and a flat or declining trend. It still sells — at a fixer-upper price, with more of the deal pushed into earnout and escrow.

The honest move is to grade your own center the way a buyer will, using the same defect list from Fixer Upper or Walk-In Ready, and then decide: take the fixer-upper price now, or spend 12–24 months renovating and go to market walk-in-ready. On a multi-million-dollar imaging group, that renovation window is routinely worth more than any negotiating tactic.

Will the Buyer Keep Your Team — or Replace It?

Sellers present their best month. Buyers underwrite the trend and the org chart — and the two together decide whether your management is an asset they keep or a cost they cut.

• If the trend is up and operations are institutionalized, the buyer keeps the team, pays a fuller multiple, and may want only light involvement from you. Your management is part of the value.
• If you are the rainmaker — referrals flow through your relationships, the schedule fills because of you — the buyer sees key-man risk. They respond by locking you into an employment agreement, weighting the earnout toward your retention, and discounting for the transition. The business cannot yet run without you, and they price that.
• If the trend is down, the buyer assumes they will need to strengthen or replace management and absorb the disruption. That assumption is priced in before you ever see the number, and it is the quietest discount of all.

The lesson sellers miss: a buyer is not buying last year. They are buying the slope of the last couple of years and the question of whether the business survives your departure. If you have never seen your own center the way that slope reads, you are negotiating against someone who has modeled little else.

The Gap, Decomposed — and the Two Business Unit Swing

Here is how the group from the opening got from roughly $12.0M to about $9.4M — a multi-center SE Florida group, a stated EBITDA near $2.4M, and a 5x number in the owner's head.

Illustrative composite — not a valuation method Benefique certifies.

Read that honestly: about two-thirds of the gap — roughly $1.75M — came from normalization carried at the headline multiple, not from clever buyer tactics. The remaining ~$0.85M came from the buyer refusing one blended multiple on a business that is really two businesses with two risk profiles. Both levers are real money, and the second is the one most general-practice advisors miss.

Sophisticated buyers price that mix risk separately — some with an explicit divisional multiple, others with a single blended multiple plus quality-of-earnings haircuts, but either way distinguishing the PET Tracer Unit — high-reimbursement tracers with roughly $2,500–$3,000 per-dose input costs depending on agent and contract (PSMA agents run higher still) and reimbursement that ranges from $0 on a denial or self-pay write-off to several thousand dollars when covered — from the Radiology Unit (MRI, CT, ultrasound, X-ray, standard PET). This is the Two Business Unit Framework we apply inside every engagement, and at sale time it moves the price directly.

The counterintuitive result: a center more dependent on PET tracer income for its profit often earns a lower blended multiple, not a higher one — even though PET produces the most revenue and gross-margin dollars per claim — because that income is concentrated, payer-variable, and carries a large tracer cost incurred before the claim is collected (and lost entirely on a denial or no-show). Show a buyer a durable radiology base with PET as upside and you defend the multiple. Hand them a blended P&L and they assume the worst about the mix. The seller who has read their own per-modality profitability negotiates from a far stronger position than the one who learns it from the buyer's report.

Quality of Earnings: Disarm the Reset Before the Data Room Opens

A buyer-side Quality of Earnings analysis is not an audit — it is a forensic reconstruction of defensible, forward-looking earnings, and on a sale of any size the buyer will run one. The only question is whether you ran yours first. The principle that value tracks defensible earning capacity and risk is old: the IRS leaned on it in Revenue Ruling 59-60 back in 1959, for a different purpose — valuing closely held stock for estate and gift tax. A QofE applies the same instinct to a sale. Run yours first and you remove the buyer's reset leverage in advance.

Sell-side QofE readiness, in practice:

1. Build the buyer's EBITDA bridge yourself — every add-back labeled "will survive" or "will get cut," with documentation attached to each survivor.
2. Separate the two business units — clean PET Tracer vs Radiology P&L, with per-claim and per-modality economics, so the mix tells your story instead of the buyer's.
3. Stress the revenue durability — referrer concentration, payer mix, LOP yield. Find the haircuts before the buyer does, then fix them or price them in.
4. Reconcile your three sources — operational billing data, the accounting system, and bank-grade aged receivables — to a tight, explainable variance, so the receivables credibility removes one common reset lever.
5. Normalize owner compensation to market — so your Adjusted EBITDA is the number a platform buyer will actually underwrite, not one you have to defend.

If you are financing the buyer's side instead, the SBA's acquisition-financing programs underwrite to that same defensible-earnings number — one more reason the seller who has it ready closes faster and cleaner.

Most accounting firms see a profitable imaging center and stop at the tax return. We read the same books the way a buyer's diligence team will — separating the durable business from the volatile one, testing which dollars survive a forward look, and translating "profit" into the language a buyer underwrites. That is the same operator's-eye view we describe on our about page. To be clear about scope: this is financial-readiness work — a defensible estimate of your Adjusted EBITDA and the diligence findings most likely to move price. It is not a certified business valuation or M&A advisory; for a formal valuation opinion or to run the transaction, we coordinate with credentialed valuation and investment-banking specialists.

The number a buyer pays is not the number on your P&L. It is the number that survives the data room — and that number can be estimated, strengthened, and improved years before you ever sign an LOI.

The owner from the opening did not take the roughly $9.4M reset. He walked, and spent about a year renovating: separating his two business units, diversifying a concentrated referral base, ending the "one-time" legal expense for real, and building several quarters of improving trend a buyer could see. That work did two things — it grew the earnings modestly, and, more powerfully, it de-risked the PET line. His defensible Adjusted EBITDA climbed to roughly $2.2M, and the PET income, no longer concentrated, re-rated from its 3.5x discount back toward a full multiple — which, alongside the earnings growth, is what carried the recovery. Run as two units, a radiology base near 5.0x plus a de-risked PET line approaching it landed him near $11.0M — not the fantasy $12M, but about $1.6M more than the data room would have paid the first time, with far less of it trapped in earnout. More than the money, he walked into the second negotiation knowing exactly which number he was defending and why.

Frequently Asked Questions

How much is my imaging center worth in 2026? SE Florida imaging centers typically trade between roughly 2.5x and 8x earnings, depending on size, payer mix, equipment age, and revenue durability — and premium multi-center platforms can run higher. Owner-operated single centers are often priced on a 1.5x–3x SDE multiple; centers above about $1M EBITDA and multi-center platforms on Adjusted EBITDA. The right number inside the band is decided in diligence, not in the LOI.

Why does a private-equity buyer lower the price after the LOI? The LOI is a non-binding offer whose main job is to win your exclusivity. Once you sign the no-shop, the diligence team can reset the price using your own add-backs, deferred capex, and revenue-concentration gaps. It is a structural feature of the process, not necessarily bad faith — which is why running your own Quality of Earnings first removes most of the leverage.

What deal terms matter besides the multiple when selling an imaging center? Cash at close, rollover equity, earnout, escrow/holdback, the working-capital peg, reps and warranties, and the employment agreement plus non-compete. A high headline multiple can hide that only a portion is certain cash at close — a 6x with heavy rollover and an earnout might put roughly 3x in your pocket on day one, with the rest contingent or illiquid.

What is rollover equity, and is it good or bad? Rollover equity is the portion of the price you re-invest into the buyer's platform, usually 20%–40%. It can be a valuable "second bite" if the platform sells higher later — or a trap that leaves you a minority holder with no control on a private-equity timeline, often junior to the sponsor's preferred return. Whether it is good depends entirely on the platform's quality, leverage, and governance, which you should diligence as hard as they diligence you.

Will a buyer keep my staff and management? It depends on the trend and how dependent the business is on you. If operations are institutionalized and trending up, buyers tend to keep the team and pay more. If you are the rainmaker or the trend is declining, buyers price in key-man risk or management change — and discount accordingly.

What is the difference between SDE and EBITDA? SDE adds one owner's full salary and perks back to EBITDA, because a small-practice buyer steps into the owner's seat. Adjusted EBITDA subtracts a market-rate replacement manager, because a platform buyer hires one. Using a platform EBITDA multiple on an SDE number double-counts the owner's pay and inflates the expectation by a full salary.

Thinking about selling — or already holding an LOI? A Strategic Radiology Review reconstructs a defensible estimate of your Adjusted EBITDA, separates your PET Tracer and Radiology units with clean per-unit economics, grades your center fixer-upper vs walk-in-ready, and surfaces the diligence findings most likely to move price — before you sign a no-shop. Fixed fee, two-week turnaround. Start the conversation →

Disclaimer: This article is for informational purposes only and does not constitute tax, legal, financial, valuation, or investment-banking advice. Tax situations and business valuations vary — consult a qualified professional for advice specific to your circumstances. Benefique provides financial-readiness analysis, not certified business valuations or M&A advisory services. Practice examples are anonymized composites drawn from more than one engagement; identifying details and figures have been changed.